Skip to content
National Association of Attorneys General
  • Issues
    • Issues
      • Anticorruption
      • Antitrust
      • Bankruptcy
      • Charities
      • Civil Law
    • Issues
      • Consumer Protection
      • Criminal Law
      • Cyber and Technology
      • Disaster Preparedness & Response
      • Elder Justice
    • Issues
      • Ethics
      • Human Trafficking
      • Medicaid Fraud
      • Opioids
      • Powers & Duties
    • Issues
      • Public Health
      • The U.S. Supreme Court
      • Tobacco
      • Veterans & Military
  • Our Work
    • Training & Research
    • Centers
      • Center for Supreme Court Advocacy
      • Center for Tobacco & Public Health
      • Center for Consumer Protection
    • Committees
    • Initiatives
      • Presidential Initiative
      • Strategic Partnerships
      • ConsumerResources.org
      • International Fellows
      • COVID-19
    • Bankruptcy
    • Policy & Advocacy
  • Events & Training
    • Event Calendar
    • Attorney General Symposium
    • Presidential Summit
    • Capital Forum
    • Region Meetings
    • CLE Credit
    • NAAG Trainings
    • Online Learning
    • NAMFCU Trainings
    • NAAG Faculty
  • News & Resources
    • Attorney General Journal
    • Reports & Publications
    • Newsroom
    • NAAG Policy Letters
    • Podcasts
    • Online Learning
    • Research & Data
    • Member Directory
  • Attorneys General
    • What Attorneys General Do
    • Who is my Attorney General?
    • Attorneys General Office 101
    • Research & Data
    • Awards & Recognition
    • Careers in Attorney General Offices
    • Careers in Medicaid Fraud Control Units
  • About NAAG
    • NAAG Staff
    • NAAG Leadership
    • NAAG Member Services
    • NAAG Regions
    • NAAG FAQs
    • SAGE
    • NAMFCU
    • Newsroom
    • Careers at NAAG
  • Find my AG
  • About NAMFCU
    • About the Medicaid Fraud Control Units
    • Reporting Fraud and Abuse
    • MFCU Member Hub
    • Careers with a MFCU
  • Contact Us
National Association of Attorneys General
  • Find My AG
  • Consumer Complaints
  • Member Benefits
  • Contact Us
Log In
  • Issues
    • Issues
      • Anticorruption
      • Antitrust
      • Bankruptcy
      • Charities
      • Civil Law
    • Issues
      • Consumer Protection
      • Criminal Law
      • Cyber and Technology
      • Disaster Preparedness & Response
      • Elder Justice
    • Issues
      • Ethics
      • Human Trafficking
      • Medicaid Fraud
      • Opioids
      • Powers & Duties
    • Issues
      • Public Health
      • The U.S. Supreme Court
      • Tobacco
      • Veterans & Military
  • Our Work
    • Training & Research
    • Centers
      • Center for Supreme Court Advocacy
      • Center for Tobacco & Public Health
      • Center for Consumer Protection
    • Committees
    • Initiatives
      • Presidential Initiative
      • Strategic Partnerships
      • ConsumerResources.org
      • International Fellows
      • COVID-19
    • Bankruptcy
    • Policy & Advocacy
  • Events & Training
    • Event Calendar
    • Attorney General Symposium
    • Presidential Summit
    • Capital Forum
    • Region Meetings
    • CLE Credit
    • NAAG Trainings
    • Online Learning
    • NAMFCU Trainings
    • NAAG Faculty
  • News & Resources
    • Attorney General Journal
    • Reports & Publications
    • Newsroom
    • NAAG Policy Letters
    • Podcasts
    • Online Learning
    • Research & Data
    • Member Directory
  • Attorneys General
    • What Attorneys General Do
    • Who is my Attorney General?
    • Attorneys General Office 101
    • Research & Data
    • Awards & Recognition
    • Careers in Attorney General Offices
    • Careers in Medicaid Fraud Control Units
  • About NAAG
    • NAAG Staff
    • NAAG Leadership
    • NAAG Member Services
    • NAAG Regions
    • NAAG FAQs
    • SAGE
    • NAMFCU
    • Newsroom
    • Careers at NAAG
  • Find my AG
  • About NAMFCU
    • About the Medicaid Fraud Control Units
    • Reporting Fraud and Abuse
    • MFCU Member Hub
    • Careers with a MFCU
  • Contact Us

Supreme Court Report: Ruan v. United States, 20-1410; Kahn v. United States, 21-5261

Home / Supreme Court / Supreme Court Report: Ruan v. United States, 20-1410; Kahn v. United States, 21-5261
November 9, 2021 Supreme Court
Share this

  • Dan Schweitzer
    Director, Center for Supreme Court Advocacy
    National Association of Attorneys General

November 9, 2021
Volume 29, Issue 3

This Report summarizes cases granted review on October 29 and November 5, 2021 (Part I).

Cases Granted Review: Ruan v. United States, 20-1410; Kahn v. United States, 21-5261

Ruan v. United States, 20-1410; Kahn v. United States, 21-5261. At issue is “whether a physician alleged to have prescribed controlled substances outside the usual course of professional practice may be convicted under [21 U.S.C. §]841(a)(1) without regard to whether, in good faith, he ‘reasonably believed’ or ‘subjectively intended’ that his prescriptions fall within that course of professional practice.” Petitioner Xiulu Ruan and his business partner are doctors who prescribed enormous amounts of oxycodone, morphine, and fentanyl to their patients between January 2011 and May 2015. They each made more than $3.7 million from their medical clinic and more than $550,000 in prescription service fees from the affiliated pharmacy they operated. Finding they were operating a “pill mill,” the federal government investigated their practices and then obtained a grand jury indictment against them. A jury convicted Ruan and his partner of multiple controlled substances and related charges. Ruan had proposed a good faith instruction that read: “Good faith in this context means good intentions and the honest exercise of professional judgment as to the patient’s needs. It means that the Defendant acted in accordance with what he reasonably believed to be proper medical practice.” The district court rejected the instruction because “good faith,” in its view, is “subjective,” and “the standard should be an objective one.” The court instead instructed the jury that “a medical doctor has violated section 841 when the government has proved beyond a reasonable doubt that the doctor’s actions were either not for a legitimate medical purpose or were outside the usual course of professional medical practice.” Ruan and his partner appealed, raising, among other issues, the district court’s treatment of their good faith defense. The Eleventh Circuit affirmed their convictions. 966 F.3d 1101. It held that the instruction given by the district court was correct. In the panel’s view, a physician may assert good faith only “as long as [his] conduct also was in accordance with the standards of medical practice generally recognized and accepted in the United States.”

Ruan argues that the Eleventh Circuit sapped the good faith defense of any independent meaning, by having it apply only to physicians whose prescriptions already fall within professional norms. In Ruan’s view, the circuits are divided into three camps on the issue of how a good faith defense applies to §841(a)(1) prosecutions. “To overcome a good faith defense in the Second, Fourth, and Sixth Circuits, the government must prove that the physician did not reasonably believe that his prescriptions fell within professional norms. To overcome a good faith defense in the First, Seventh, and Ninth Circuits, the government must prove that the physician subjectively intended a prescription to exceed professional norms. But neither of those ‘good faith’ defenses is available in the Eleventh Circuit. All it takes to convict a physician under the CSA is a finding that the doctor prescribed controlled substances outside generally accepted medical standards.” On the merits, he argues that “[a] meaningful good faith instruction helps ensure that convictions under the [Controlled Substances Act] are consistent with the ‘basic principle’ that ‘an injury is criminal only if inflicted knowingly.’” By contrast, he says, “the Eleventh Circuit’s rule reads any meaningful scienter requirement out of the statute.”

[Editor’s note: Some of the language in the background section of the summary above was taken from the petition for writ of certiorari and brief in opposition.]

Related Posts

Related Posts

Supreme Court Report, Volume 31, Issue 20

Supreme Court Report, Volume 31, Issue 13

Supreme Court Report, Volume 32, Issue 6

Connect with NAAG and the Attorney General Community

Create a NAAG account to subscribe to our newsletters or mailing lists.

Create Account
Subscribe
Marble columns and the top of a federal building

scroll to filters

White Logo for the National Association of Attorneys General

1850 M Street NW
12th floor
Washington, DC 20036

TEL 202-326-6000
EMAIL 

Youtube
  • Issues
    • Issues
      • Anticorruption
      • Antitrust
      • Bankruptcy
      • Charities
      • Civil Law
    • Issues
      • Consumer Protection
      • Criminal Law
      • Cyber and Technology
      • Disaster Preparedness & Response
      • Elder Justice
    • Issues
      • Ethics
      • Human Trafficking
      • Medicaid Fraud
      • Opioids
      • Powers & Duties
    • Issues
      • Public Health
      • The U.S. Supreme Court
      • Tobacco
      • Veterans & Military
  • Our Work
    • Training & Research
    • Centers
      • Center for Supreme Court Advocacy
      • Center for Tobacco & Public Health
      • Center for Consumer Protection
    • Committees
    • Initiatives
      • Presidential Initiative
      • Strategic Partnerships
      • ConsumerResources.org
      • International Fellows
      • COVID-19
    • Bankruptcy
    • Policy & Advocacy
  • Events & Training
    • Event Calendar
    • Attorney General Symposium
    • Presidential Summit
    • Capital Forum
    • Region Meetings
    • CLE Credit
    • NAAG Trainings
    • Online Learning
    • NAMFCU Trainings
    • NAAG Faculty
  • News & Resources
    • Attorney General Journal
    • Reports & Publications
    • Newsroom
    • NAAG Policy Letters
    • Podcasts
    • Online Learning
    • Research & Data
    • Member Directory
  • Attorneys General
    • What Attorneys General Do
    • Who is my Attorney General?
    • Attorneys General Office 101
    • Research & Data
    • Awards & Recognition
    • Careers in Attorney General Offices
    • Careers in Medicaid Fraud Control Units
  • About NAAG
    • NAAG Staff
    • NAAG Leadership
    • NAAG Member Services
    • NAAG Regions
    • NAAG FAQs
    • SAGE
    • NAMFCU
    • Newsroom
    • Careers at NAAG
  • Find my AG
  • About NAMFCU
    • About the Medicaid Fraud Control Units
    • Reporting Fraud and Abuse
    • MFCU Member Hub
    • Careers with a MFCU
  • Contact Us
  • Find My AG
  • Consumer Complaints
  • Member Benefits
  • Contact Us
  • Accessibility Statement
  • Privacy & Cookies Notice
  • Sitemap
  • Member Login

About the National Association of Attorneys General

As the nonpartisan national forum for America's state and territory attorneys general and their staff, NAAG provides collaboration, insight, and expertise to empower and champion America's attorneys general.
Learn More

© 2025 Copyright National Association of Attorneys General

Website by Yoko Co

Internal Feedback / Report an Error

Request an Update / Report an Error

The change you are requesting will be linked to this page. The URL for the page will be included in a hidden field when the form is submitted.
Please enter your change or describe your request. Be sure to reference where the error appears on the page and what needs to be done specifically.
Upload any files that need to be linked to this page. PDF only. Submit another request if you have more than five files to upload.
Drop files here or
Accepted file types: pdf, docx, xls, Max. file size: 50 MB, Max. files: 5.

    Who is requesting this change?(Required)

    Scroll To Top

    Insert/edit link

    Enter the destination URL

    Or link to existing content

      No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.
        To provide you more clarity about how we collect, store and use personal information, and your rights to control that information, we have updated our privacy policy, which also explains how we use cookies. You consent to our cookies if you continue to use our website.I Agree